Key facts
| Company | Stavis Seafoods, LLC |
|---|---|
| FDA office | Office of Inspections and Investigations |
| Letter date | April 15, 2026 |
| Subject / product | Seafood HACCP/CGMP for Foods/Adulterated/Insanitary Conditions |
| CFR citations | FDA Warning Letter |
| Response due | 15 working days from receipt (standard FDA warning-letter requirement) |
| Reference / source ID | stavis-seafoods-llc-727785-04152026 |
What happens next
Stavis Seafoods, LLC is expected to respond to FDA in writing, typically within 15 working days of the letter date, describing the specific corrective and preventive actions taken or planned for each violation cited. FDA reviews that response and any follow-up evidence, and can conduct a re-inspection to confirm the corrections were actually made. If FDA judges the response inadequate, or the underlying conditions serious enough, further action can follow, including product seizure, injunction, import alert, or civil penalties; many Warning Letters are resolved through corrective action alone. This page reflects the Warning Letter as issued and will not reflect any subsequent correction unless FDA publishes a follow-up record. FDA issues Warning Letters after an inspection or other review when it believes a firm has significantly violated FDA regulations; the letter itself is a notice, not a final adjudication.
Violations explained
FDA Warning Letter — Violations FDA cited at Stavis Seafoods, LLC
WARNING LETTER Stavis Seafoods, LLC MARCS-CMS 727785 — April 15, 2026 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: Via Email Product: Food & Beverages Recipient: Recipient Name Juan Lopez Martinez Recipient Title CEO Stavis Seafoods, LLC 1 Seafood Way Boston , MA 02210-2702 United States (b)(6), (b)(7)(C) Issuing Office: Office of Inspections and Investigations United States 04/15/2026 WARNING LETTER RE: CMS# 724267 Dear Mr. Martinez: On February 03, 2026, through February 05, 2026, the Food and Drug Administration (FDA) conducted an inspection of your seafood importer establishment, Stavis Seafoods, LLC located at 1 Seafood Way, Boston, MA 02210-2702. We also conducted an inspection from June 11 through June 13, 2024. We found that you have serious violations of the seafood Hazard Analysis and Critical Control Point (HACCP) regulation, Title 21, Code of Federal Regulations, Part 123 (21 CFR Part 123). The specific requirements for imported fish and fishery products are set out in 21 CFR 123.12. As an importer of fish or fishery products, you must operate in accordance with the requirements of Part 123. In accordance with 21 CFR 123.12(d), there must be evidence that all fish and fishery products offered for entry into the United States have been processed under conditions that comply with 21 CFR Part 123. If assurances do not exist that the imported fish or fishery product has been processed under conditions that are equivalent to those required of domestic processors under 21 CFR Part 123, the fish or fishery products will appear to be adulterated under Section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act (the Act), 21 U.S.C. § 342(a)(4) and will be denied entry. Because our inspection identified serious violations for 21 CFR Part 123, your frozen aquaculture salmon fillets are adulterated under Section 402(a)(4) of the Act (21 U.S.C. § 342(a)(4)), in that they have been prepared, packed, or held under insanitary conditions whereby they may have been rendered injurious to health. You may find the Act, the seafood HACCP regulation and the Fish and Fisheries Products Hazards & Controls Guidance through links in FDA's home page at www.fda.gov. Your significant violations are as follows: You do not have or have not implemented an affirmative step for ensuring that fish and fishery products you import are processed in compliance with the Seafood HACCP regulation, as required by 21 CFR 123.12(a)(2)(ii). Specifically, your firm did not implement an affirmative step for ensuring that the frozen aquaculture salmon fillets you import from (b)(4) located in (b)(4) are processed in compliance with the Seafood HACCP regulation. We may take further action if you do not promptly correct these violations. For instance, we may take further action to refuse admission of your imported fish or fishery products under Section 801(a) of the Act (21 U.S.C. § 381(a)), including placing them on "detention without physical examination," seize your product(s) and/or enjoin your firm from further violating the Act. You should respond in writing within fifteen (15) working days from your receipt of this letter. Your response should outline the specific things you are doing to correct these violations. You should include in your response documentation, such as HACCP and importer verification records and records that document the performance and results of your firm’s affirmative steps, or other useful information that would assist us in evaluating your corrections. If you cannot complete all corrections before you respond, you should explain the reason for your delay and state when you will correct any remaining violations. This letter may not list all the violations at your facility. You are responsible for ensuring that your seafood importer establishment operates in compliance with the Act and the seafood HACCP regulation (21 CFR Part 123). You also have a responsibility to use procedures to prevent
Stavis Seafoods, LLC’s FDA history
Argus HQ has recorded 1 total FDA action tied to Stavis Seafoods, LLC: 1 warning letter, 0 recalls, 0 approval records, and 0 Form 483 inspection citations.
Full letter text
Read the rest of the full text
Frequently asked questions
- Is the FDA warning letter to Stavis Seafoods, LLC publicly available?
- Yes. The full verbatim letter is published at fda.gov: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/stavis-seafoods-llc-727785-04152026.
- What is the standard FDA response window for a warning letter?
- FDA warning letters typically require a written response within 15 working days of receipt, outlining the corrective and preventive actions the company will take.
- What is an FDA Warning Letter?
- An FDA Warning Letter notifies a company that FDA believes it has significantly violated FDA regulations and that prompt corrective action is required. It is issued after an inspection, sample analysis, or other FDA review, and is a notice -- not a final legal determination and not itself a penalty.
- Does this Warning Letter mean Stavis Seafoods, LLC violated the law?
- FDA's letter documents violations it believes it found at Stavis Seafoods, LLC. A Warning Letter is not a final adjudication of guilt; the company has an opportunity to respond and correct the cited issues, and many Warning Letters are resolved without further enforcement once FDA confirms adequate correction.
Get the next warning letter in this therapeutic area before your team hears about it secondhand.
Weekly briefing, free. Upgrade any time for daily or real-time delivery.
Related enforcement actions
Full FDA history for Stavis Seafoods, LLC- Warning letter (recent): Med Shop Inc / www.medshopinc.com — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): ketaminetroches.com — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): Ketdaxandrugs / www.ketdaxandrugs.org — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): Legit Ketamine Suppliers / www.legitketaminesuppliers.com — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): Ketamine Store / www.ketaminestore.org — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): Buy Keta Online / www.buyketaonline.com — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): Ketamine Troche Store / www.ketaminetrochestore.com — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): All Ketamine HCL / www.allketaminehcl.com — Unapproved New Drugs/Misbranded (2026-06-23) →
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). Stavis Seafoods, LLC — FDA Warning Letter, April 15, 2026: Seafood HACCP/CGMP for Foods/Adulterated/Insanitary Conditions. Digital Empire LLC. Retrieved from https://argushq.ai/warning-letter/stavis-seafoods-727785-2026-04-15
"Stavis Seafoods, LLC — FDA Warning Letter, April 15, 2026: Seafood HACCP/CGMP for Foods/Adulterated/Insanitary Conditions." Argus HQ Research, Digital Empire LLC, 2026, argushq.ai/warning-letter/stavis-seafoods-727785-2026-04-15.
Argus HQ Research. "Stavis Seafoods, LLC — FDA Warning Letter, April 15, 2026: Seafood HACCP/CGMP for Foods/Adulterated/Insanitary Conditions." Digital Empire LLC. Accessed July 13, 2026. https://argushq.ai/warning-letter/stavis-seafoods-727785-2026-04-15.
@misc{argushq_argushq_ai_warning_letter_stavis_seafoods_727785_2026_04_15_2026,
title = {Stavis Seafoods, LLC — FDA Warning Letter, April 15, 2026: Seafood HACCP/CGMP for Foods/Adulterated/Insanitary Conditions},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire LLC},
url = {https://argushq.ai/warning-letter/stavis-seafoods-727785-2026-04-15},
note = {Accessed: July 13, 2026}
}Source: FDA.gov — Warning Letters ↗

